Amy M. Buckley
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Through COVID-19 and beyond: developing a multidisciplinary telehealth family intervention in first episode psychosis.
Journal: Irish journal of psychological medicine
Published: December 01, 2021
Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction.
Journal: Metabolites
Published: September 13, 2021
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis.
Journal: Intestinal research
Published: May 27, 2021
Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma.
Journal: Cancer treatment and research communications
Published: January 10, 2021
Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model.
Journal: Translational oncology
Published: June 22, 2020
Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.
Journal: BMC cancer
Published: May 18, 2020
Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers.
Journal: Nature reviews. Gastroenterology & hepatology
Published: November 26, 2019
Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib.
Journal: Scientific reports
Published: October 10, 2019
Infective endocarditis: a retrospective cohort study.
Journal: QJM : monthly journal of the Association of Physicians
Published: May 12, 2019
1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours.
Journal: Oncotarget
Published: January 01, 2019
Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 19, 2018
Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma.
Journal: Cancer letters
Published: October 01, 2018
Last Updated: 09/26/2026